A UL course
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) aims to protect patient confidentiality in the age of health information technology. This course addresses how to best implement the challenges presented by HIPAA requirements in the process of new pharmaceutical, biological, and medical device development. Participants will learn how HIPAA could impact the use of information gathered from US clinical trials.
- HIPAA compliance
- Limited data sets
- HIPAA affect on future clinical research
Who should attend?
Professionals and experts in the pharmaceutical, biotechnology, and medical device fields